+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 65Years
All Genders
ID05928767

Assessing Frailty as a Risk Factor for Mortality in Adults 18-65 with Septic Shock in Intensive Care

Led by Centre Hospitalier de Lens · Updated on 2026-09-28

200

Participants Needed

5

Research Sites

6 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to understand how frailty affects outcomes in adults aged 18 to 65 who are admitted to intensive care with septic shock. It evaluates whether being physically frail, as measured by the Clinical Frailty Scale CFS, is an independent risk factor for death and other complications. The study focuses on younger critically ill patients, exploring how frailty impacts mortality, hospital stay length, readmission risk, and quality of life after intensive care. The study observes patients admitted to intensive care for suspected or confirmed septic shock who require vasopressors and have elevated lactate levels. Frailty is assessed upon admission using the CFS, categorizing patients as frail or severely frail based on their scores. This observational study does not involve treatments but tracks patients over time to understand the impact of frailty on their outcomes. Participants are monitored for 28 and 90 days after inclusion to assess mortality, hospital stay duration, use of invasive therapies, readmissions, frailty changes, and quality of life. Researchers collect clinical data and follow patients to better predict survival and inform care decisions. The study aims to provide valuable insights for patients, families, and healthcare providers about risks and expectations related to frailty in young adults facing septic shock.

CONDITIONS

Brief Title

Evaluation of the Clinical Frailty Scale (CFS) as a Risk Factor of Mortality in Adult Patients ≤65 Years of Age Admitted to Intensive Care for Septic Shock.

Research Team

G

Guillaume DEGOUY, Dr

M

MELANIE VERLAY

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here